PlainRecalls
FDA Drug Moderate Class II Terminated

Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Reported: March 18, 2020 Initiated: February 24, 2020 #D-1008-2020

Product Description

Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901

Reason for Recall

Lack Of Processing Controls

Details

Units Affected
16 doses
Distribution
Sold to patients in Nebraska
Location
Hastings, NE

Frequently Asked Questions

What product was recalled?
Daptomycin, 500MG in 0.9% NACL 100ML Injectable Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901. Recalled by Redline Pharmacy Solutions. Units affected: 16 doses.
Why was this product recalled?
Lack Of Processing Controls
Which agency issued this recall?
This recall was issued by the FDA Drug on March 18, 2020. Severity: Moderate. Recall number: D-1008-2020.